TrialRMD open2026

A phase III, randomised, double-blind, multi-dose, placebo- and naproxen-controlled study to evaluate the efficacy and safety of fasinumab in patients with pain due to osteoarthritis of the knee or hip.

Stephen J DiMartino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.